The E3 ligase RNF43 inhibits Wnt signaling downstream of mutated β-catenin by sequestering TCF4 to the nuclear...

Area of Science:

• Molecular Biology
• Cell Biology
• Oncology

Background:

• The Wnt-β-catenin signaling pathway is critical for development and cancer.
• RING finger protein 43 (RNF43) is an E3 ubiquitin ligase that interacts with Frizzled receptors to inhibit Wnt signaling.

Purpose of the Study:

• To investigate the nuclear function and inhibitory mechanism of RNF43 in Wnt signaling.
• To determine if RNF43 mutations found in tumors affect its inhibitory activity.

Main Methods:

• Detection of endogenous RNF43 in human intestinal crypt and colon cancer cells.
• Co-immunoprecipitation to assess RNF43-TCF4 interaction.
• Analysis of TCF4 localization and transcriptional activity.
• Functional studies using mutated RNF43 in cell culture and Xenopus embryos.

Main Results:

• Endogenous RNF43 was found in the nucleus of intestinal and colon cancer cells.
• RNF43 physically interacts with T cell factor 4 (TCF4) and tethers it to the nuclear membrane, inhibiting its transcriptional activity.
• Mutations in RNF43 found in gastrointestinal tumors disrupt this inhibitory mechanism.
• Mutating the RING domain of RNF43 leads to Wnt pathway transactivation.

Conclusions:

• RNF43 acts as a nuclear inhibitor of the Wnt pathway, downstream of oncogenic mutations.
• RNF43's inhibitory function on Wnt/β-catenin signaling is crucial for controlling cellular processes and preventing cancer.
• Enhancing RNF43's inhibitory activity presents a potential therapeutic strategy for Wnt-driven cancers.